{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:32:49Z","timestamp":1792794769673,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41401-020-00538-8","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T17:03:04Z","timestamp":1602262984000},"page":"932-941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy"],"prefix":"10.1038","volume":"42","author":[{"given":"Xiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley B.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"538_CR1","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pr. 2019;157:107843.","journal-title":"Diabetes Res Clin Pr"},{"key":"538_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord. 2010;11:31\u20139.","journal-title":"Rev Endocr Metab Disord"},{"key":"538_CR3","first-page":"596","volume":"30","author":"SDJ Rubler","year":"1972","unstructured":"Rubler SDJ, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:596\u2013602.","journal-title":"Am J Cardiol"},{"key":"538_CR4","doi-asserted-by":"crossref","first-page":"656795","DOI":"10.1155\/2015\/656795","volume":"2015","author":"J Fuentes-Antras","year":"2015","unstructured":"Fuentes-Antras J, Picatoste B, Gomez-Hernandez A, Egido J, Tunon J, Lorenzo O. Updating experimental models of diabetic cardiomyopathy. J Diabetes Res. 2015;2015:656795.","journal-title":"J Diabetes Res"},{"key":"538_CR5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41401-019-0320-y","volume":"41","author":"HT Yu","year":"2020","unstructured":"Yu HT, Zhen J, Xu JX, Cai L, Leng JY, Ji HL, et al. Zinc protects against cadmium-induced toxicity in neonatal murine engineered cardiac tissues via metallothionein-dependent and independent mechanisms. Acta Pharmacol Sin. 2020;41:638\u201349.","journal-title":"Acta Pharmacol Sin"},{"key":"538_CR6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/toxsci\/kfy177","volume":"165","author":"H Yu","year":"2018","unstructured":"Yu H, Ye F, Yuan F, Cai L, Ji H, Keller BB. Neonatal murine engineered cardiac tissue toxicology model: impact of metallothionein overexpression on cadmium-induced injury. Toxicol Sci. 2018;165:499\u2013511.","journal-title":"Toxicol Sci"},{"key":"538_CR7","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01125-y","volume":"8","author":"M Kawatou","year":"2017","unstructured":"Kawatou M, Masumoto H, Fukushima H, Morinaga G, Sakata R, Ashihara T, et al. Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue. Nat Commun. 2017;8:1078.","journal-title":"Nat Commun"},{"key":"538_CR8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jacc.2017.06.061","volume":"70","author":"T Borchert","year":"2017","unstructured":"Borchert T, Hubscher D, Guessoum CI, Lam TD, Ghadri JR, Schellinger IN, et al. Catecholamine-dependent beta-adrenergic signaling in a pluripotent stem cell model of takotsubo cardiomyopathy. J Am Coll Cardiol. 2017;70:975\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"538_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfz168","volume":"172","author":"NT Feric","year":"2019","unstructured":"Feric NT, Pallotta I, Singh R, Bogdanowicz DR, Gustilo M, Chaudhary K, et al. Engineered cardiac tissues generated in the Biowire II: a platform for human-based drug discovery. Toxicol Sci. 2019;172:89\u201397.","journal-title":"Toxicol Sci"},{"key":"538_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacbts.2017.12.007","volume":"3","author":"R Truitt","year":"2018","unstructured":"Truitt R, Mu A, Corbin EA, Vite A, Brandimarto J, Ky B, et al. Increased afterload augments sunitinib-induced cardiotoxicity in an engineered cardiac microtissue model. JACC Basic Transl Sci. 2018;3:265\u201376.","journal-title":"JACC Basic Transl Sci"},{"key":"538_CR11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.stemcr.2017.09.008","volume":"9","author":"EK Lee","year":"2017","unstructured":"Lee EK, Tran DD, Keung W, Chan P, Wong G, Chan CW, et al. Machine learning of human pluripotent stem cell-derived engineered cardiac tissue contractility for automated drug classification. Stem Cell Rep. 2017;9:1560\u201372.","journal-title":"Stem Cell Rep"},{"key":"538_CR12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12048-5","volume":"7","author":"G Conant","year":"2017","unstructured":"Conant G, Ahadian S, Zhao Y, Radisic M. Kinase inhibitor screening using artificial neural networks and engineered cardiac biowires. Sci Rep. 2017;7:11807.","journal-title":"Sci Rep"},{"key":"538_CR13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.actbio.2018.09.013","volume":"80","author":"J Chen","year":"2018","unstructured":"Chen J, Zhan Y, Wang Y, Han D, Tao B, Luo Z, et al. Chitosan\/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats. Acta Biomater. 2018;80:154\u201368.","journal-title":"Acta Biomater"},{"key":"538_CR14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcell.2017.00002","volume":"5","author":"MT Valarmathi","year":"2017","unstructured":"Valarmathi MT, FuselerJW, Davis JM, Price RL. A novel human tissue-engineered 3-D functional vascularized cardiac muscle construct. Front Cell Dev Biol. 2017;5:2.","journal-title":"Front Cell Dev Biol"},{"key":"538_CR15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01946-x","volume":"8","author":"IY Shadrin","year":"2017","unstructured":"Shadrin IY, Allen BW, Qian Y, Jackman CP, Carlson AL, Juhas ME, et al. Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nat Commun. 2017;8:1825.","journal-title":"Nat Commun"},{"key":"538_CR16","doi-asserted-by":"crossref","first-page":"e0187348","DOI":"10.1371\/journal.pone.0187348","volume":"12","author":"I Rashedi","year":"2017","unstructured":"Rashedi I, Talele N, Wang XH, Hinz B, Radisic M, Keating A. Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells. PLoS ONE. 2017;12:e0187348.","journal-title":"PLoS ONE"},{"key":"538_CR17","volume":"6","author":"H Masumoto","year":"2016","unstructured":"Masumoto H, Nakane T, Tinney JP, Yuan F, Ye F, Kowalski WJ, et al. The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages. Sci Rep. 2016;6:29933.","journal-title":"Sci Rep"},{"key":"538_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fcvm.2018.00147","volume":"5","author":"M Zamani","year":"2018","unstructured":"Zamani M, Karaca E, Huang NF. Multicellular interactions in 3D engineered myocardial tissue. Front Cardiovasc Med. 2018;5:147.","journal-title":"Front Cardiovasc Med"},{"key":"538_CR19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.actbio.2018.08.003","volume":"78","author":"C Jackman","year":"2018","unstructured":"Jackman C, Li H, Bursac N. Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function. Acta Biomater. 2018;78:98\u2013110.","journal-title":"Acta Biomater"},{"key":"538_CR20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/ten.tea.2016.0535","volume":"24","author":"H Iseoka","year":"2018","unstructured":"Iseoka H, Miyagawa S, Fukushima S, Saito A, Masuda S, Yajima S, et al. Pivotal role of non-cardiomyocytes in electromechanical and therapeutic potential of induced pluripotent stem cell-derived engineered cardiac tissue. Tissue Eng Part A. 2018;24:287\u2013300.","journal-title":"Tissue Eng Part A"},{"key":"538_CR21","doi-asserted-by":"crossref","first-page":"7648409","DOI":"10.1155\/2017\/7648409","volume":"2017","author":"CE Rupert","year":"2017","unstructured":"Rupert CE, Coulombe KLK. IGF1 and NRG1 enhance proliferation, metabolic maturity, and the force-frequency response in hesc-derived engineered cardiac tissues. Stem Cells Int. 2017;2017:7648409.","journal-title":"Stem Cells Int"},{"key":"538_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biomaterials.2017.09.001","volume":"146","author":"M An","year":"2017","unstructured":"An M, Kwon K, Park J, Ryu DR, Shin JA, Lee Kang J, et al. Extracellular matrix-derived extracellular vesicles promote cardiomyocyte growth and electrical activity in engineered cardiac atria. Biomaterials 2017;146:49\u201359.","journal-title":"Biomaterials"},{"key":"538_CR23","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1093\/eurheartj\/ehy249","volume":"39","author":"D Mosqueira","year":"2018","unstructured":"Mosqueira D, Mannhardt I, Bhagwan JR, Lis-Slimak K, Katili P, Scott E, et al. CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Eur Heart J. 2018;39:3879\u201392.","journal-title":"Eur Heart J"},{"key":"538_CR24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.stemcr.2018.10.006","volume":"11","author":"JGW Smith","year":"2018","unstructured":"Smith JGW, Owen T, Bhagwan JR, Mosqueira D, Scott E, Mannhardt I, et al. Isogenic pairs of hiPSC-CMs with hypertrophic cardiomyopathy\/LVNC-associated ACTC1E99K mutation unveil differential functional deficits. Stem Cell Rep. 2018;11:1226\u201343.","journal-title":"Stem Cell Rep"},{"key":"538_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yjmcc.2018.05.007","volume":"119","author":"DK Ceholski","year":"2018","unstructured":"Ceholski DK, Turnbull IC, Kong CW, Koplev S, Mayourian J, Gorski PA, et al. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 2018;119:147\u201354.","journal-title":"J Mol Cell Cardiol"},{"key":"538_CR26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1745-7254.2005.00146.x","volume":"26","author":"LE Wold","year":"2005","unstructured":"Wold LE, Ceylan-Isik AF, Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin. 2005;26:908\u201317.","journal-title":"Acta Pharmacol Sin"},{"key":"538_CR27","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1745-7254.2005.00240.x","volume":"26","author":"G Cheng","year":"2005","unstructured":"Cheng G, Wang LL, Qu WS, Long L, Cui H, Liu HY, et al. C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats. Acta Pharmacol Sin. 2005;26:1460\u20136.","journal-title":"Acta Pharmacol Sin"},{"key":"538_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-013-9374-y","volume":"19","author":"VL Bodiga","year":"2014","unstructured":"Bodiga VL, Eda SR, Bodiga S. Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail Rev. 2014;19:49\u201363.","journal-title":"Heart Fail Rev"},{"key":"538_CR29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1139\/cjpp-2015-0073","volume":"94","author":"J Hou","year":"2016","unstructured":"Hou J, Zheng D, Fung G, Deng H, Chen L, Liang J, et al. Mangiferin suppressed advanced glycation end products (AGEs) through NF-kappaB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats. Can J Physiol Pharmacol. 2016;94:332\u201340.","journal-title":"Can J Physiol Pharmacol"},{"key":"538_CR30","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Luo W, Han J, Khan ZA, Fang Q, Jin Y, et al. MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. Nat Commun. 2020;11:2148.","journal-title":"Nat Commun"},{"key":"538_CR31","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.4049\/jimmunol.1202862","volume":"190","author":"J Lu","year":"2013","unstructured":"Lu J, Wu DM, Zheng YL, Hu B, Cheng W, Zhang ZF, et al. Troxerutin counteracts domoic acid-induced memory deficits in mice by inhibiting CCAAT\/enhancer binding protein beta-mediated inflammatory response and oxidative stress. J Immunol. 2013;190:3466\u201379.","journal-title":"J Immunol"},{"key":"538_CR32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17:585\u2013607.","journal-title":"Nat Rev Cardiol."},{"key":"538_CR33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrendo.2017.161","volume":"14","author":"M Kleinert","year":"2018","unstructured":"Kleinert M, Clemmensen C, Hofmann SM, Moore MC, Renner S, Woods SC, et al. Animal models of obesity and diabetes mellitus. Nat Rev Endocrinol. 2018;14:140\u201362.","journal-title":"Nat Rev Endocrinol"},{"key":"538_CR34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","volume":"166","author":"AJ King","year":"2012","unstructured":"King AJ. The use of animal models in diabetes research. Br J Pharmacol. 2012;166:877\u201394.","journal-title":"Br J Pharmacol"},{"key":"538_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.08.108","volume":"99","author":"A King","year":"2016","unstructured":"King A, Bowe J. Animal models for diabetes: Understanding the pathogenesis and finding new treatments. Biochem Pharmacol. 2016;99:1\u201310.","journal-title":"Biochem Pharmacol"},{"key":"538_CR36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbalip.2003.07.002","volume":"1636","author":"CG Schalkwijk","year":"2004","unstructured":"Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW. NiessenHW. Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl) lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim Biophys Acta. 2004;1636:82\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"538_CR37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI119180","volume":"99","author":"ED Schleicher","year":"1997","unstructured":"Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 1997;99:457\u201368.","journal-title":"J Clin Invest"},{"key":"538_CR38","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1582-4934.2008.00547.x","volume":"13","author":"H Ma","year":"2009","unstructured":"Ma H, Li SY, Xu P, Babcock SA, DolenceEK, Brownlee M, et al. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med. 2009;13:1751\u201364.","journal-title":"J Cell Mol Med"},{"key":"538_CR39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.20452\/pamw.1821","volume":"123","author":"E Grzebyk","year":"2013","unstructured":"Grzebyk E, Knapik\u2011Kordecka M, Piwowar A. Advanced glycation end-products and cathepsin cysteine protease in type 2 diabetic patients. Pol Arch Intern Med 2013;123:364\u201370.","journal-title":"Pol Arch Intern Med"},{"key":"538_CR40","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/diacare.20.6.1006","volume":"20","author":"J Tore","year":"1997","unstructured":"Tore J, Berg KD-J, Torjesen PeterA, Hanssen KristianF. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Diabetes Care. 1997;20:1006\u20138.","journal-title":"Diabetes Care"},{"key":"538_CR41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","volume":"92","author":"R Candido","year":"2003","unstructured":"Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 2003;92:785\u201392.","journal-title":"Circ Res"},{"key":"538_CR42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxlet.2017.11.018","volume":"284","author":"Z Pei","year":"2018","unstructured":"Pei Z, Deng Q, Babcock SA, He EY, Ren J, Zhang Y. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: role of autophagy and ER stress. Toxicol Lett. 2018;284:10\u201320.","journal-title":"Toxicol Lett"},{"key":"538_CR43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fphys.2012.00292","volume":"3","author":"AL Kranstuber","year":"2012","unstructured":"Kranstuber AL, Del Rio C, Biesiadecki BJ, Hamlin RL, Ottobre J, Gyorke S, et al. Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling. Front Physiol. 2012;3:292.","journal-title":"Front Physiol"},{"key":"538_CR44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fgene.2017.00187","volume":"8","author":"LM Senatus","year":"2017","unstructured":"Senatus LM, Schmidt AM. The AGE-RAGE axis: implications for age-associated arterial diseases. Front Genet. 2017;8:187.","journal-title":"Front Genet"},{"key":"538_CR45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semnephrol.2007.01.006","volume":"27","author":"AL Tan","year":"2007","unstructured":"Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol. 2007;27:130\u201343.","journal-title":"Semin Nephrol"},{"key":"538_CR46","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.micinf.2004.08.004","volume":"6","author":"T Chavakis","year":"2004","unstructured":"Chavakis T, Bierhaus A, Nawroth PP. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 2004;6:1219\u201325.","journal-title":"Microbes Infect"},{"key":"538_CR47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.diabres.2018.11.016","volume":"148","author":"P Jud","year":"2019","unstructured":"Jud P, Sourij H. Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: a review. Diabetes Res Clin Pr. 2019;148:54\u201363.","journal-title":"Diabetes Res Clin Pr"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00538-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T15:17:54Z","timestamp":1633879074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00538-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00538-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"5 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}